OSR Holdings, Inc. Price & Performance (OSRH)

Bellevue Life Sciences Acquisition Corp. has officially rebranded as OSR Holdings, Inc. following the approval of a significant business combination proposal. The merger positions the newly named OSR Holdings as a global healthcare player, with plans to leverage its subsidiaries in oncology, age-related diseases, and medical devices.12

The Dow Jones fell 150 points, or 0.33%, as U.S. housing starts dropped 9.8% in January. The decline in construction activity signals potential economic challenges, with the NASDAQ and S&P 500 also experiencing losses. Energy stocks, however, provided some relief, rising by 1.6% during the trading session.3

OSR Holdings has entered into an $80 million equity financing agreement with White Lion GBM Innovation Fund. The deal offers OSR financial flexibility amid market volatility, enabling the company to sell shares at its discretion. This move aims to strengthen its operations within the competitive medical device sector.4